Stock screener

BLCO

SetupConviction 44LongHealthcareScan · Thu, Jun 25, 2026
Downtrendchannel
BLCO$15.94+2.77%
ResistanceSupportVol 14
63 bars
Vol MA14 412.55K
Mar 26Apr 14May 1May 19Jun 8Jun 25

Trade plan

LongReward : Risk0.93
Entry
Entry
16.20
Risk
Stop
14.62
-9.8% to stop
Reward
Target 1
17.68
+9.1% to target
Stretch
Target 2
19.16
+18.2% to T2
Risk : reward balance
Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

Bausch & Lomb CorpOPHTHALMIC GOODSwww.bausch.com
Price15.94
Change+2.77%
Gap+0.45%
Rel volume1.30×
Avg volume487.12K
Avg $ vol7.43M
SMA 2015.25
SMA 5015.76
SMA 20016.15
Price vs 50+1.13%
Price vs 200-1.28%
MA stackmixed
50/200 cross
Supertrenddown · 16.06
RSI (14)60
MACD hist0.09
MACD crossbull · 2d
Stoch %K / %D93 / 72
ADX (14)22
+DI / −DI24 / 17
RSI divergenceBullish
MACD divergenceBullish
ATR %+2.67%
ADR %2.57%
52w high18.60
52w low12.07
From 52w high-14.30%
Above 52w low+32.06%
New 52w highNo
SqueezeFired
Bollinger width7.94%
%B1.07
Donchian pos93.48%
Donchian high16.03
Donchian low14.65
AVWAP (52w high)16.09
vs AVWAP high-0.96%
AVWAP (52w low)15.41
vs AVWAP low+3.45%
OBV trendFlat
Chaikin MF (20)-0.05
Today vs 20d1.30×
Avg vol (14d)412.55K
Avg vol (20d)487.12K
Avg $ vol (20d)7.43M
Market cap5.68B
RS 3m (vs SPY)-13.53%
RS 6m (vs SPY)-16.39%
RS line new highNo
Trend template5/8
Technical rank46.9
1 week+7.27%
1 month+1.01%
3 months-0.50%
6 months-5.79%
1 year+32.39%
YTD-3.86%
P/E-15.79
P/B0.89
P/S1.11
P/FCF-86.11
EPS-1.02
Div yield
ROE-5.64%
ROA-2.61%
Debt/Eq0.79
Current1.53
EV/EBITDA19.58
Gross margin
Net margin-7.06%
Rev growth6.47%
EPS growth-13.56%
Price target18.29
Target upside14.74%
Analyst ratingHold
Institutional10.69%
Ent. value10.45B
Revenue1.24B
Net income-71M
Gross profit
Free cash flow-66M
IndustryOPHTHALMIC GOODS
ExchangeNYSE
Shares out357.04M
Employees13K
ListedFri, May 6, 2022
Free float43.32M
Float %12.2%
Short interest4.06M
Days to cover10.2d
Short volume22.6%
Squeeze score48 / 100
Next earningsWed, Jul 29, 2026 (34d)
EPS forecast$0.16 · 5 est
Last EPS vs est$0.08 vs $0.06
Last surprise+33.3% beat
Setup gradeD
Conviction44 / 100
Pattern quality65%
Tech rank46.9 / 100
Group rank50 / 100
Status laneSetting up
Setup directionLong
Pattern familyChannel
Resistance16.20
Support14.73
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BLCO

All disclosures →
No recent disclosed trades by Congress in BLCO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BLCO · 9 buys · 1 sell

InsiderSideShares
Bonnefoy Luc
President, Surgical · Common Shares, No Par Value · 2026-06-12
Tax1.01K
Alfonso Eduardo
Director · Common Shares, No Par Value · 2026-05-26
Grant15.84K
COLLIS STEVEN H
Director · Common Shares, No Par Value · 2026-05-26
Grant15.84K
Ling Karen
Director · Common Shares, No Par Value · 2026-05-26
Grant15.84K
Ross Thomas W. Sr.
Director · Common Shares, No Par Value · 2026-05-26
Grant15.84K
Paulson John
Director · Common Shares, No Par Value · 2026-05-26
Grant15.84K
Bernier Nathalie D.
Director · Common Shares, No Par Value · 2026-05-26
Grant15.84K
ROBERTSON RUSSEL C
Director · Common Shares, No Par Value · 2026-05-26
Grant15.84K
KAVANAGH SARAH B
Director · Common Shares, No Par Value · 2026-05-26
Grant15.84K
VON ESCHENBACH ANDREW C.
Director · Common Shares, No Par Value · 2026-05-26
Grant15.84K

SEC filings

EDGAR filings in BLCO

EDGAR →

No recent SEC filings on file for BLCO.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.